Paul Chaplin
Chief Executive Officer presso BAVARIAN NORDIC A/S
Posizioni attive di Paul Chaplin
Società | Posizione | Inizio | Fine |
---|---|---|---|
BAVARIAN NORDIC A/S | Chief Executive Officer | 28/05/2014 | - |
President | 28/05/2014 | - | |
Chief Tech/Sci/R&D Officer | 01/01/2004 | 10/02/2012 | |
Corporate Officer/Principal | 10/02/2012 | 28/05/2014 | |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Corporate Officer/Principal | 03/03/2011 | - |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | President | - | - |
Storia della carriera di Paul Chaplin
Formazione di Paul Chaplin
University of Bristol | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Danimarca | 2 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 2 |
President | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
Aziende private | 2 |
---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
- Borsa valori
- Insiders
- Paul Chaplin
- Esperienza